Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Operating Leases (2022 - 2025)

Biofrontera (BFRI) has 4 years of Operating Leases data on record, last reported at $136000.0 in Q3 2025.

  • For Q3 2025, Operating Leases fell 58.02% year-over-year to $136000.0; the TTM value through Sep 2025 reached $136000.0, down 58.02%, while the annual FY2024 figure was $276000.0, 65.67% down from the prior year.
  • Operating Leases reached $136000.0 in Q3 2025 per BFRI's latest filing, down from $223000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $848000.0 in Q4 2022 and bottomed at $136000.0 in Q3 2025.
  • Average Operating Leases over 4 years is $471090.9, with a median of $443000.0 recorded in 2024.
  • Peak YoY movement for Operating Leases: decreased 5.19% in 2023, then crashed 65.67% in 2024.
  • A 4-year view of Operating Leases shows it stood at $848000.0 in 2022, then dropped by 5.19% to $804000.0 in 2023, then plummeted by 65.67% to $276000.0 in 2024, then plummeted by 50.72% to $136000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Leases were $136000.0 in Q3 2025, $223000.0 in Q2 2025, and $220000.0 in Q1 2025.